CHINESE JOURNAL OF MEDICINAL GUIDE >
The Application of Digital Therapeutics in Patients with Chronic Obstructive Pulmonary Disease
Received date: 2024-07-24
Revised date: 2025-03-12
Accepted date: 2025-04-25
Online published: 2025-08-06
Supported by
基于“互联网+”的延续护理模式对慢阻肺 患者自我管理的研究(D202314019314)
Objective： To investigate the effect of digital therapy on chronic obstructive pulmonary disease （COPD） patients.Methods： A total of 40 COPD patients admitted to a tertiary-level hospital in Zhangjiajie from June 2023 to March 2024 were selected as research subjects and randomly divided into the experimental group and the control group， each with 20 cases. The control group received conventional nursing methods， while the experimental group， in addition to the conventional nursing methods， implemented remote dynamic monitoring of COPD patients through the digital therapy platform， real-time monitoring and feedback of patients' drug use and exercise， and patients' health information was collected. The modified British Medical Research Council dyspnea scale （mMRC） score， quality of life index （chronic obstructive pulmonary disease assessment test， CAT） score， pulmonary function， the test of the adherence to inhalers （TAI） score， pressure metered-dose inhaler （pMDI） inhalation skills assessment， depression screening scale （PHQ-9）， and generalized anxiety disorder self-assessment scale （GAD-7） were compared before and after intervention in both groups. In addition， the software satisfaction score was collected in the experimental group.Results： The results showed that there was no significant difference in mMRC scores between the two groups before intervention （P>0.05）； and the mMRC grading of the experimental group was lower than that of the control group after intervention （P<0.05）， there was no significant difference in CAT scores between the two groups before intervention （P>0.05）， and CAT scores of the experimental group was lower than that of the control group after intervention （P<0.05）. There was no significant difference in pulmonary function between the two groups before intervention （P>0.05）， and pulmonary function of the experimental group had improved more than that of the control group after intervention （P<0.05）. There was no significant difference in TAI scores between the two groups before intervention （P>0.05）， and TAI scores of the experimental group was higher than that of the control group after intervention （P<0.05）. There was no significant difference in pressure metered dose inhaler （pMDI） skills assessment scores between the two groups before intervention （P>0.05）， and pMDI skills assessment scores of the experimental group was higher than that of the control group after intervention （P<0.05）. There was no significant difference in PHQ-9 and GAD-7 scores between the two groups before intervention and after intervention （P>0.05）.Conclusion： Digital therapeutics can improve the overall condition of COPD patients， but the effect on anxiety and depression needs further research.
Key words： ; Digital therapeutics； ; Chronic obstructive pulmonary disease ; （COPD）； ; Anxiety and depression
Nie-Su NIE
.
The Application of Digital Therapeutics in
Patients with Chronic Obstructive Pulmonary Disease
［1］ Iheanacho I， Zhang S， King D， et al. Economic burden of chronic obstructive pulmonary disease （COPD）： a systematic literature review［J］.Int J Chron Obstruct Pulmon Dis，2020，15：439-460.
［2］ Nici L. Improving the lives of individuals with chronic respiratory disease： the need for innovation［J］.Thorax，2022，77（7）：636-637.
［3］ Prevalence and attributable health burden of chronic respiratory diseases， 1990-2017： a systematic analysis for the Global Burden of Disease Study 2017［J］.Lancet Respir Med，2020，8（6）：585-596.
［4］ Yin P， Wu J， Wang L， et al. The burden of COPD in China and its provinces： findings from the Global Burden of Disease Study 2019［J］.Front Public Health，2022，10：859499.
［5］ Liang Y， Sun Y. COPD in China： current status and challenges［J］.Arch Bronconeumol，2022，58（12）：790-791.
［6］ Lindenauer PK， Dharmarjan K， Qin L， et al. Risk trajectories of readmission and death in the first year after hospitalization for chronic obstructive pulmonary disease［J］.Am J Respir Crit Care Med，2018，197（8）：1009-1017.
［7］ Press VG， Au DH， Bourbeau J， et al. Reducing Chronic Obstructive Pulmonary Disease hospital readmissions. an official american thoracic society workshop report［J］.Ann Am Thorac Soc，2019，16（2）：161-170.
［8］ Dang A， Arora D， Rane P. Role of digital therapeutics and the changing future of healthcare［J］.J Family Med Prim Care，2020，9（5）：2207-2213.
［9］ Halpin DMG， Criner GJ， Papi A， et al. Global initiative for the diagnosis， management， and prevention of Chronic Obstructive Lung Disease. The 2020 GOLD science committee report on COVID-19 and Chronic Obstructive Pulmonary Disease［J］.Am J Respir Crit Care Med，2021，203（1）：24-36.
［10］ Sunjaya A， Poulos L， Reddel H， et al. Qualitative validation of the modified Medical Research Council （mMRC） dyspnoea scale as a patient-reported measure of breathlessness severity［J］.Respir Med，2022，203：106984.
［11］ Pott J， Krill A， Wilkens H， et al. Easy measurement of health related quality of life in patients with cystic fibrosis by the COPD assessment test （CAT）—A pilot study［J］.Respir Med，2020，168：105992.
［12］ 陈丽琴，林俏丽.COPD患者知信行认知情况与CAT评分的相关性及影响因素调查［J］.临床肺科杂志，2023，28（2）：225-229.
［13］ 孟玮玮，崔亚楠，罗丽娟，等.吸入药物依从性测试中文版的信效度研究［J］.中华结核和呼吸杂志，2022，45（5）：423-430.
［14］ Kroenke K， Spitzer RL， Williams JB. The PHQ-9： validity of a brief depression severity measure［J］.J Gen Intern Med，2001，16（9）：606-613.
［15］ García-campayo J， Zamorano E， Ruiz MA， et al. Cultural adaptation into Spanish of the generalized anxiety disorder-7 （GAD-7） scale as a screening tool［J］.Health Qual Life Outcomes，2010，8： 8.
［16］ O'donnell DE， Milne KM， James MD， et al. Dyspnea in COPD： new mechanistic insights and management implications［J］.Adv Ther，2020，37（1）：41-60.
［17］ Zhou A， Zhou Z， Peng Y， et al. The role of CAT in evaluating the response to treatment of patients with AECOPD［J］.Int J Chron Obstruct Pulmon Dis，2018，13：2849-2858.
［18］ 孟现玲，何玉廷，毛若琳，等.圣乔治呼吸问卷、CAT及mMRC评分在慢性阻塞性肺病中的应用［J］.复旦学报（医学版），2022，49（6）：862-868，876.
［19］ Sunjaya AP， Sengupta A， Martin A， et al. Efficacy of self-management mobile applications for patients with breathlessness： Systematic review and quality assessment of publicly available applications［J］.Respir Med， 2022， 201： 106947.
［20］ Zanaboni P， Dinesen B， Hoaas H， et al. Long-term telerehabilitation or unsupervised training at home for patients with Chronic Obstructive Pulmonary Disease： a randomized controlled trial［J］.Am J Respir Crit Care Med，2023，207（7）：865-875.
［21］ Pauwels RA， Buist AS， Calverley PM， et al. Global strategy for the diagnosis， management， and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease （GOLD） Workshop summary［J］.Am J Respir Crit Care Med，2001，163（5）：1256-1276.
［22］ Aburub A， Darabseh MZ， Badran， et al. The effects of digital health interventions for pulmonary rehabilitation in people with COPD： a systematic review of randomized controlled trials［J］.Medicina （Kaunas），2024，60（6）：693.
［23］ Wang L， HEL， Tao Y， et al. Evaluating a web-based coaching program using electronic health records for patients with Chronic Obstructive Pulmonary Disease in China： randomized controlled trial［J］.J Med Internet Res，2017，19（7）：e264.
［24］ Hoaas H， Andreassen HK， Lien LA， et al. Adherence and factors affecting satisfaction in long-term telerehabilitation for patients with chronic obstructive pulmonary disease： a mixed methods study［J］.BMC Med Inform Decis Mak，2016，16：26.
［25］ Vrijens B， Dima AL， Van Ganse E， et al. What we mean when we talk about adherence in respiratory medicine［J］.J Allergy Clin Immunol Pract，2016，4（5）：802-812.
［26］ 李庆云，孙娴雯.慢性阻塞性肺疾病稳定期管理的几个新视点：2021版GOLD指南解读 ［J］. 诊断学理论与实践，2021，20（1）：43-47.
［27］ 岑芸，马小琴.老年人用药依从性自身影响因素的研究进展［J］.护理与康复，2021，20（11）：32-36.
［28］ Uchmanowicz B， Chudiak A， Uchmanowicz I， et al. Factors influencing adherence to treatment in older adults with hypertension［J］.Clinical interventions in aging，2018，13：2425-2441.
［29］ Safren S A， Gonzalez JS， Wexier DJ， et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression （CBT-AD） in patients with uncontrolled type 2 diabetes［J］.Diabetes care，2014，37（3）：625-633.
［30］ Shah A， Hussain-shamsy N， Strudwick G， et al. Digital health interventions for depression and anxiety among people with chronic conditions： scoping review［J］.J Med Internet Res，2022，24（9）：e38030.
/
| 〈 |
|
〉 |